SCHEMBL3678768

SCHEMBL3678768

O=c1[nH]cnc2c1CSC=C2

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
TSHR P16473 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CHEK1 O14757 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
SRC P12931 2/20 0.33
GAA P10253 1/20 0.33
PDPK1 O15530 4/20 0.33
PARP1 P09874 2/20 0.33
KDM4A O75164 1/20 0.32
KDM4B O94953 1/20 0.32
KDM5C P41229 1/20 0.32
KDM4C Q9H3R0 1/20 0.32
KDM5B Q9UGL1 1/20 0.32
KDM3A Q9Y4C1 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
CA12 O43570 1/20 0.31
ALOX15 P16050 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL856432 0.72 ALDH1A1 (0.39) ALDH1A1TSHRNPSR1CHEK1HTT
SCHEMBL1437156 0.69 ALDH1A1 (0.36) ALDH1A1TSHRNPSR1CHEK1HTT
Hydrochloric Acid SCHEMBL8486646 0.69 SRC (0.37) ALDH1A1TSHRNPSR1CHEK1HTT
SCHEMBL3675974 0.68 ALDH1A1 (0.35) ALDH1A1TSHRNPSR1CHEK1HTT
SCHEMBL15416608 0.66 SRC (0.35) ALDH1A1NPSR1SRCEGFR
SCHEMBL17825573 0.64 ALDH1A1 (0.39) ALDH1A1TSHRNPSR1CHEK1HTT
SCHEMBL2796721 0.64 SRC (0.39) ALDH1A1TSHRNPSR1CHEK1HTT
SCHEMBL7776871 0.61 PARP1 (0.50) ALDH1A1TSHRNPSR1CHEK1HTT
SCHEMBL1073971 0.60
SCHEMBL3542410 0.58 NPSR1 (0.49) ALDH1A1TSHRNPSR1CHEK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7799775-B2 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome ASKA PHARMACEUTICAL CO., LTD. (JP) 2010-09-21 US disclosed
US-20070197551-A1 Pyrimidine derivatives ASKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197551-A1 Pyrimidine derivatives HTR3B, HTR3A, HTR1A ALDH1A1 2838/4885TSHR 1069/4885NPSR1 30/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.